Do not forget the original Phenoxodiol under Kelly's original Novogen and its subsidiary Marshall Edwards that had been "proven to work" and then blew up costing many people millions of $$$. Do not count on it until they have patents issued, a deal and an FDA approval. Multiple hard lessons learned in terms of inexact science, trial design, the way data is reported, people, their motives, over selling and believing too much. GLTA
Ann: Noxopharm IONIC Immuno-Oncology Trial Commences, page-10
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.014(14.6%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 9.2¢ | 11.5¢ | 9.2¢ | $53.30K | 518.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 48681 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 74195 | 4 |
View Market Depth
| Last trade - 15.45pm 23/08/2024 (20 minute delay) ? |
| NOX (ASX) Chart |